ArticleClinical ophthalmology (Auckland, N.Z.)2016
Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab.
Yoshihito Sakanishi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it